281 related articles for article (PubMed ID: 29875054)
1. The Differential Diagnosis and Treatment of Thrombotic Microangiopathies.
Bommer M; Wölfle-Guter M; Bohl S; Kuchenbauer F
Dtsch Arztebl Int; 2018 May; 115(19):327-334. PubMed ID: 29875054
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
3. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.
Scully M; Cataland S; Coppo P; de la Rubia J; Friedman KD; Kremer Hovinga J; Lämmle B; Matsumoto M; Pavenski K; Sadler E; Sarode R; Wu H;
J Thromb Haemost; 2017 Feb; 15(2):312-322. PubMed ID: 27868334
[TBL] [Abstract][Full Text] [Related]
4. Atypical hemolytic uremic syndrome (aHUS): making the diagnosis.
Laurence J
Clin Adv Hematol Oncol; 2012 Oct; 10(10 Suppl 17):1-12. PubMed ID: 23187605
[TBL] [Abstract][Full Text] [Related]
5. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
[TBL] [Abstract][Full Text] [Related]
6. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli.
Nakayama S; Hirashio S; Yorishima H; Doi T; Yoshida Y; Matsumoto M; Masaki T
CEN Case Rep; 2019 Nov; 8(4):266-270. PubMed ID: 31177384
[TBL] [Abstract][Full Text] [Related]
7. HUS and TTP: traversing the disease and the age spectrum.
Donadelli R; Sinha A; Bagga A; Noris M; Remuzzi G
Semin Nephrol; 2023 Jul; 43(4):151436. PubMed ID: 37949684
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
Clark WF
Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
[TBL] [Abstract][Full Text] [Related]
9. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
Williams LA; Marques MB;
Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
[TBL] [Abstract][Full Text] [Related]
10. Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Wada H; Matsumoto T; Yamashita Y
Semin Thromb Hemost; 2014 Nov; 40(8):866-73. PubMed ID: 25377323
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic microangiopathy in a 17-year-old patient: TTP, HUS or a bit of both?
Gerth J; Busch M; Oyen F; Schneppenheim R; Keller T; Budde U; Groene HJ; Wolf G
Clin Nephrol; 2007 Dec; 68(6):405-11. PubMed ID: 18184524
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
Shenkman B; Einav Y
Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic microangiopathies: multimers, metalloprotease, and beyond.
Moake J
Clin Transl Sci; 2009 Oct; 2(5):366-73. PubMed ID: 20443921
[TBL] [Abstract][Full Text] [Related]
15. Syndromes of Thrombotic Microangiopathy.
Shatzel JJ; Taylor JA
Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178
[TBL] [Abstract][Full Text] [Related]
16. Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: clinically differentiating the thrombotic microangiopathies.
Cataland SR; Wu HM
Eur J Intern Med; 2013 Sep; 24(6):486-91. PubMed ID: 23739653
[TBL] [Abstract][Full Text] [Related]
17. [Hemolytic and uremic syndrome and related thrombotic microangiopathies: Epidemiology, pathophysiology and clinics].
Rafat C; Coppo P; Fakhouri F; Frémeaux-Bacchi V; Loirat C; Zuber J; Rondeau E
Rev Med Interne; 2017 Dec; 38(12):817-824. PubMed ID: 28711159
[TBL] [Abstract][Full Text] [Related]
18. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
Laurence J; Haller H; Mannucci PM; Nangaku M; Praga M; Rodriguez de Cordoba S
Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620
[TBL] [Abstract][Full Text] [Related]
19. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
Mannucci PM; Cugno M
Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
